Abstract
Cystic Fibrosis (CF) is a chronic, multi-system disorder that primarily affects the lungs, and pancreas, and leads to significant and progressive bronchiectasis, and subsequently end-stage lung disease. Sleep disturbances in cystic fibrosis include nocturnal hypoxemia due to a variety of physiologic changes including ventilation-perfusion mismatch, changes in mechanics of breathing. Derecruitment of ventilatory muscles, particularly during REM sleep and resultant hypoventilation may also be contributory, and may also lead to sleep-disordered breathing in these patients. Other potential causes of sleep disruption in CF patients include nocturnal wheezing and cough, as well as side effects of medications such as β-agonists, as well as chronic pain syndromes. It is likely that sleep fragmentation contributes significantly to impaired quality of life in CF patients. Nocturnal ventilation has been shown to improve symptoms, reverse hypoventilation and increase exercise capacity in CF patients.
Keywords: Sleep, cystic fibrosis, bronchospasm, nocturnal respiratory failure
Current Respiratory Medicine Reviews
Title: Sleep Disturbances in Cystic Fibrosis
Volume: 5 Issue: 4
Author(s): Amarbir S. Mattewal and Shyamsunder Subramanian
Affiliation:
Keywords: Sleep, cystic fibrosis, bronchospasm, nocturnal respiratory failure
Abstract: Cystic Fibrosis (CF) is a chronic, multi-system disorder that primarily affects the lungs, and pancreas, and leads to significant and progressive bronchiectasis, and subsequently end-stage lung disease. Sleep disturbances in cystic fibrosis include nocturnal hypoxemia due to a variety of physiologic changes including ventilation-perfusion mismatch, changes in mechanics of breathing. Derecruitment of ventilatory muscles, particularly during REM sleep and resultant hypoventilation may also be contributory, and may also lead to sleep-disordered breathing in these patients. Other potential causes of sleep disruption in CF patients include nocturnal wheezing and cough, as well as side effects of medications such as β-agonists, as well as chronic pain syndromes. It is likely that sleep fragmentation contributes significantly to impaired quality of life in CF patients. Nocturnal ventilation has been shown to improve symptoms, reverse hypoventilation and increase exercise capacity in CF patients.
Export Options
About this article
Cite this article as:
Mattewal S. Amarbir and Subramanian Shyamsunder, Sleep Disturbances in Cystic Fibrosis, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112401
DOI https://dx.doi.org/10.2174/157339809790112401 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Functionalization of Imidazo[1,2-a]Pyridines and Imidazo[1,2-a]Pyrimidines on Solid Phase Using Suzuki-Miyaura Cross-Coupling Reactions
Letters in Organic Chemistry The De Novo Synthesis of Oligosaccharides: Application to the Medicinal Chemistry SAR-Study of Digitoxin
Current Topics in Medicinal Chemistry Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis
Current Pharmaceutical Design Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Evaluation and Management of Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Management of Patients with Heart Failure: Focus on New Pharmaceutical and Device Options
Current Medicinal Chemistry The Prodigiosins: A New Family of Anticancer Drugs
Current Cancer Drug Targets Eltrombopag Induced Thrombosis: A Case with Acute Myocardial Infarction
Current Drug Safety Transient Left Ventricular Acute Failure after Cocaine Use
Current Drug Research Reviews Calcium Channels and Prostate Cancer
Recent Patents on Anti-Cancer Drug Discovery Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient Drug
Current Drug Targets (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) ATP Hydrolysis-Dependent Multidrug Efflux Transporter: MDR1 / Pglycoprotein
Current Drug Metabolism Interrupting the Natural History of Diabetes Mellitus: Lifestyle, Pharmacological and Surgical Strategies Targeting Disease Progression
Current Vascular Pharmacology Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Genetics and Bioenergetics of Mitochondria Influencing the Etiology and Pharmacology of Steroidal Hormones
Current Pharmacogenomics A Review of the Ethnopharmacology, Phytochemistry and Pharmacology of Plants of the Maytenus Genus
Current Pharmaceutical Design Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Current Pharmaceutical Design Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia
Current Pharmaceutical Design Natural AMPK Activators: An Alternative Approach for the Treatment and Management of Metabolic Syndrome
Current Medicinal Chemistry